RESUMEN
Regulatory T cells (Tregs) are plastic cells playing a pivotal role in the maintenance of immune homeostasis. Tregs actively adapt to the microenvironment where they reside; as a consequence, their molecular and functional profiles differ among tissues and pathologies. In tumors, the features acquired by Tregs remains poorly characterized. Here, we observe that human tumor-infiltrating Tregs selectively overexpress CD74, the MHC class II invariant chain. CD74 has been previously described as a regulator of antigen-presenting cell biology, however its function in Tregs remains unknown. CD74 genetic deletion in human primary Tregs reveals that CD74KO Tregs exhibit major defects in the organization of their actin cytoskeleton and intracellular organelles. Additionally, intratumoral CD74KO Tregs show a decreased activation, a drop in Foxp3 expression, a low accumulation in the tumor, and consistently, they are associated with accelerated tumor rejection in preclinical models in female mice. These observations are unique to tumor conditions as, at steady state, CD74KO-Treg phenotype, survival, and suppressive capacity are unaffected in vitro and in vivo. CD74 therefore emerges as a specific regulator of tumor-infiltrating Tregs and as a target to interfere with Treg anti-tumor activity.
Asunto(s)
Antígenos de Diferenciación de Linfocitos B , Antígenos de Histocompatibilidad Clase II , Linfocitos T Reguladores , Linfocitos T Reguladores/inmunología , Animales , Antígenos de Diferenciación de Linfocitos B/metabolismo , Antígenos de Diferenciación de Linfocitos B/genética , Antígenos de Diferenciación de Linfocitos B/inmunología , Antígenos de Histocompatibilidad Clase II/metabolismo , Antígenos de Histocompatibilidad Clase II/inmunología , Antígenos de Histocompatibilidad Clase II/genética , Humanos , Femenino , Ratones , Factores de Transcripción Forkhead/metabolismo , Factores de Transcripción Forkhead/genética , Microambiente Tumoral/inmunología , Neoplasias/inmunología , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/patología , Linfocitos Infiltrantes de Tumor/inmunología , Linfocitos Infiltrantes de Tumor/metabolismo , Ratones Endogámicos C57BL , Ratones NoqueadosRESUMEN
BACKGROUND: Recent evidence has shown dopamine as a major regulator of inflammation. Accordingly, dopaminergic regulation of immune cells plays an important role in the physiopathology of inflammatory disorders. Multiple sclerosis (MS) is an inflammatory disease involving a CD4+ T-cell-driven autoimmune response to central nervous system (CNS) derived antigens. Evidence from animal models has suggested that B cells play a fundamental role as antigen-presenting cells (APC) re-stimulating CD4+ T cells in the CNS as well as regulating T-cell response by mean of inflammatory or anti-inflammatory cytokines. Here, we addressed the role of the dopamine receptor D3 (DRD3), which displays the highest affinity for dopamine, in B cells in animal models of MS. METHODS: Mice harbouring Drd3-deficient or Drd3-sufficient B cells were generated by bone marrow transplantation into recipient mice devoid of B cells. In these mice, we compared the development of experimental autoimmune encephalomyelitis (EAE) induced by immunization with a myelin oligodendrocyte glycoprotein (MOG)-derived peptide (pMOG), a model that leads to CNS-autoimmunity irrespective of the APC-function of B cells, or by immunization with full-length human MOG protein (huMOG), a model in which antigen-specific activated B cells display a fundamental APC-function in the CNS. APC-function was assessed in vitro by pulsing B cells with huMOG-coated beads and then co-culturing with MOG-specific T cells. RESULTS: Our data show that the selective Drd3 deficiency in B cells abolishes the disease development in the huMOG-induced EAE model. Mechanistic analysis indicates that although DRD3-signalling did not affect the APC-function of B cells, DRD3 favours the CNS-tropism in a subset of pro-inflammatory B cells in the huMOG-induced EAE model, an effect that was associated with higher CXCR3 expression. Conversely, the results show that the selective Drd3 deficiency in B cells exacerbates the disease severity in the pMOG-induced EAE model. Further analysis shows that DRD3-stimulation increased the expression of the CNS-homing molecule CD49d in a B-cell subset with anti-inflammatory features, thus attenuating EAE manifestation in the pMOG-induced EAE model. CONCLUSIONS: Our findings demonstrate that DRD3 in B cells exerts a dual role in CNS-autoimmunity, favouring CNS-tropism of pro-inflammatory B cells with APC-function and promoting CNS-homing of B cells with anti-inflammatory features. Thus, these results show DRD3-signalling in B cells as a critical regulator of CNS-autoimmunity.
Asunto(s)
Autoinmunidad/fisiología , Linfocitos B/metabolismo , Dopamina/metabolismo , Encefalomielitis Autoinmune Experimental/metabolismo , Receptores de Dopamina D3/metabolismo , Secuencia de Aminoácidos , Animales , Linfocitos B/inmunología , Células Cultivadas , Sistema Nervioso Central/inmunología , Sistema Nervioso Central/metabolismo , Dopamina/inmunología , Encefalomielitis Autoinmune Experimental/genética , Encefalomielitis Autoinmune Experimental/inmunología , Femenino , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Receptores de Dopamina D3/genética , Receptores de Dopamina D3/inmunologíaRESUMEN
The formation of an immune synapse (IS) enables B cells to capture membrane-tethered antigens, where cortical actin cytoskeleton remodeling regulates cell spreading and depletion of F-actin at the centrosome promotes the recruitment of lysosomes to facilitate antigen extraction. How B cells regulate both pools of actin, remains poorly understood. We report here that decreased F-actin at the centrosome and IS relies on the distribution of the proteasome, regulated by Ecm29. Silencing Ecm29 decreases the proteasome pool associated to the centrosome of B cells and shifts its accumulation to the cell cortex and IS. Accordingly, Ecm29-silenced B cells display increased F-actin at the centrosome, impaired centrosome and lysosome repositioning to the IS and defective antigen extraction and presentation. Ecm29-silenced B cells, which accumulate higher levels of proteasome at the cell cortex, display decreased actin retrograde flow in lamellipodia and enhanced spreading responses. Our findings support a model where B the asymmetric distribution of the proteasome, mediated by Ecm29, coordinates actin dynamics at the centrosome and the IS, promoting lysosome recruitment and cell spreading.
RESUMEN
LAT is an important player of the signaling cascade induced by TCR activation. This adapter molecule is present at the plasma membrane of T lymphocytes and more abundantly in intracellular compartments. Upon T cell activation the intracellular pool of LAT is recruited to the immune synapse (IS). We previously described two pathways controlling LAT trafficking: retrograde transport from endosomes to the TGN, and anterograde traffic from the Golgi to the IS. We address the specific role of four proteins, the GTPase Rab6, the t-SNARE syntaxin-16, the v-SNARE VAMP7 and the golgin GMAP210, in each pathway. Using different methods (endocytosis and Golgi trap assays, confocal and TIRF microscopy, TCR-signalosome pull down) we show that syntaxin-16 is regulating the retrograde transport of LAT whereas VAMP7 is regulating the anterograde transport. Moreover, GMAP210 and Rab6, known to contribute to both pathways, are in our cellular context, specifically and respectively, involved in anterograde and retrograde transport of LAT. Altogether, our data describe how retrograde and anterograde pathways coordinate LAT enrichment at the IS and point to the Golgi as a central hub for the polarized recruitment of LAT to the IS. The role that this finely-tuned transport of signaling molecules plays in T-cell activation is discussed.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Sinapsis Inmunológicas/metabolismo , Proteínas de la Membrana/metabolismo , Vesículas Transportadoras/metabolismo , Transporte Biológico , Endocitosis , Humanos , Células Jurkat , Cinética , Modelos Biológicos , Proteínas R-SNARE/metabolismo , Sintaxina 16/metabolismo , Proteínas de Unión al GTP rab/metabolismoRESUMEN
Upon interaction with immobilized antigens, B cells form an immune synapse where actin remodeling and re-positioning of the microtubule-organizing center (MTOC) together with lysosomes can facilitate antigen extraction. B cells have restricted cytoplasmic space, mainly occupied by a large nucleus, yet the role of nuclear morphology in the formation of the immune synapse has not been addressed. Here we show that upon activation, B cells re-orientate and adapt the size of their nuclear groove facing the immune synapse, where the MTOC sits, and lysosomes accumulate. Silencing the nuclear envelope proteins Nesprin-1 and Sun-1 impairs nuclear reorientation towards the synapse and leads to defects in actin organization. Consequently, B cells are unable to internalize the BCR after antigen activation. Nesprin-1 and Sun-1-silenced B cells also fail to accumulate the tethering factor Exo70 at the center of the synaptic membrane and display defective lysosome positioning, impairing efficient antigen extraction at the immune synapse. Thus, changes in nuclear morphology and positioning emerge as critical regulatory steps to coordinate B cell activation.
Asunto(s)
Actinas , Receptores de Antígenos de Linfocitos B , Actinas/metabolismo , Antígenos/metabolismo , Linfocitos B , Receptores de Antígenos de Linfocitos B/metabolismo , Sinapsis/metabolismoRESUMEN
The ability of B lymphocytes to capture external antigens (Ag) and present them as peptide fragments, loaded on major histocompatibility complex (MHC) class II molecules, to CD4+ T cells is a crucial part of the adaptive immune response. This allows for T-B cooperation, a cellular communication that is required for B cells to develop into germinal centers (GC) and form mature high affinity antibody producing cells and to further develop B cell memory. MHC class II antigen presentation by B lymphocytes is a multistep process involving (1) Recognition and capture of external Ag by B lymphocytes through their B cell receptor (BCR), (2) Ag processing, which comprises the degradation of Ag in internal compartments within the B cell and loading of the corresponding peptide fragments on MHC class II molecules, and (3) Presentation of MHCII-peptide complexes to CD4+ T cells. Here, we describe how to study the biochemical and morphological changes that occur in B lymphocytes at these three major levels.
Asunto(s)
Presentación de Antígeno/inmunología , Antígenos/metabolismo , Linfocitos B/inmunología , Antígenos de Histocompatibilidad Clase II/inmunología , Proteínas Inmovilizadas/metabolismo , Animales , Línea Celular , Activación de Linfocitos/inmunología , Ratones , Bazo/citología , Membranas Sinápticas/metabolismoRESUMEN
B lymphocytes capture antigens from the surface of presenting cells by forming an immune synapse. Local secretion of lysosomes, which are guided to the synaptic membrane by centrosome repositioning, can facilitate the extraction of immobilized antigens. However, the molecular basis underlying their delivery to precise domains of the plasma membrane remains elusive. Here we show that microtubule stabilization, triggered by engagement of the B cell receptor, acts as a cue to release centrosome-associated Exo70, which is redistributed to the immune synapse. This process is coupled to the recruitment and activation of GEF-H1, which is required for assembly of the exocyst complex, used to promote tethering and fusion of lysosomes at the immune synapse. B cells silenced for GEF-H1 or Exo70 display defective lysosome secretion, which results in impaired antigen extraction and presentation. Thus, centrosome repositioning coupled to changes in microtubule stability orchestrates the spatial-temporal distribution of the exocyst complex to promote polarized lysosome secretion at the immune synapse.
Asunto(s)
Presentación de Antígeno/genética , Linfocitos B/inmunología , Sinapsis Inmunológicas/genética , Factores de Intercambio de Guanina Nucleótido Rho/genética , Proteínas de Transporte Vesicular/genética , Animales , Presentación de Antígeno/inmunología , Antígenos de Superficie/genética , Antígenos de Superficie/inmunología , Membrana Celular/inmunología , Polaridad Celular/genética , Polaridad Celular/inmunología , Centrosoma/inmunología , Exocitosis/genética , Exocitosis/inmunología , Lisosomas/genética , Lisosomas/inmunología , Ratones , Microtúbulos/genética , Microtúbulos/inmunología , Receptores de Antígenos de Linfocitos B/genética , Receptores de Antígenos de Linfocitos B/inmunologíaRESUMEN
Engagement of the B cell receptor (BCR) with surface-tethered antigens leads to the formation of an immune synapse (IS), where cell signaling and antigen uptake are tightly coordinated. Centrosome re-orientation to the immune synapse has emerged as a critical regulatory step to guide the local recruitment and secretion of lysosomes, which can facilitate the extraction of immobilized antigens. This process is coupled to actin remodeling at the centrosome and at the immune synapse, which is crucial to promote cell polarity. How B cells balance both pools of actin cytoskeleton to achieve a polarized phenotype during the formation of an immune synapse is not fully understood. Here, we reveal that B cells rely on proteasome activity to achieve this task. The proteasome is a multi-catalytic protease that degrades cytosolic and nuclear proteins and its dysfunction is associated with diseases, such as cancer and autoimmunity. Our results show that resting B cells contain an active proteasome pool at the centrosome, which is required for efficient actin clearance at this level. As a result of proteasome inhibition, activated B cells do not deplete actin at the centrosome and are unable to separate the centrosome from the nucleus and thus display impaired polarity. Consequently, lysosome recruitment to the immune synapse, antigen extraction and presentation are severely compromised in B cells with diminished proteasome activity. Additionally, we found that proteasome inhibition leads to impaired actin remodeling at the immune synapse, where B cells display defective spreading responses and distribution of key signaling molecules at the synaptic membrane. Overall, our results reveal a new role for the proteasome in regulating the immune synapse of B cells, where the intracellular compartmentalization of proteasome activity controls cytoskeleton remodeling between the centrosome and synapse, with functional repercussions in antigen extraction and presentation.
Asunto(s)
Actinas/metabolismo , Antígenos/metabolismo , Linfocitos B/fisiología , Sinapsis Inmunológicas/inmunología , Complejo de la Endopetidasa Proteasomal/fisiología , Animales , Polaridad Celular , Centrosoma/fisiología , Ratones , Ratones Endogámicos C57BL , Receptores de Antígenos de Linfocitos B/fisiología , Transducción de Señal/fisiología , Quinasa Syk/fisiologíaRESUMEN
Complete activation of B cells relies on their capacity to extract tethered antigens from immune synapses by either exerting mechanical forces or promoting their proteolytic degradation through lysosome secretion. Whether antigen extraction can also be tuned by local cues originating from the lymphoid microenvironment has not been investigated. We here show that the expression of Galectin-8-a glycan-binding protein found in the extracellular milieu, which regulates interactions between cells and matrix proteins-is increased within lymph nodes under inflammatory conditions where it enhances B cell arrest phases upon antigen recognition in vivo and promotes synapse formation during BCR recognition of immobilized antigens. Galectin-8 triggers a faster recruitment and secretion of lysosomes toward the B cell-antigen contact site, resulting in efficient extraction of immobilized antigens through a proteolytic mechanism. Thus, extracellular cues can determine how B cells sense and extract tethered antigens and thereby tune B cell responses in vivo.
Asunto(s)
Presentación de Antígeno/inmunología , Antígenos de Superficie/metabolismo , Linfocitos B/inmunología , Galectinas/metabolismo , Sinapsis Inmunológicas/metabolismo , Animales , Linfocitos B/citología , Puntos de Control del Ciclo Celular , Línea Celular , Pollos , Ganglios Linfáticos/metabolismo , Lisosomas/metabolismo , Ratones Endogámicos C57BL , Unión Proteica , Proteolisis , Ratas , Receptores de Antígenos de Linfocitos B/metabolismo , Linfocitos T/citologíaRESUMEN
Recognition of surface-tethered antigens (Ags) by B-cells leads to the formation of an immune synapse that promotes Ag uptake for presentation onto MHC-II molecules. Extraction of immobilized Ags at the immune synapse of B-cells relies on the local secretion of lysosomes, which are recruited to the Ag contact site by polarization of their microtubule network. Although conserved polarity proteins have been implicated in coordinating cytoskeleton remodeling with lysosome trafficking, the cellular machinery associated with lysosomal vesicles that regulates their docking and secretion at the synaptic interface has not been defined. Here we show that the v-SNARE protein Vamp-7 is associated with Lamp-1+ lysosomal vesicles, which are recruited and docked at the center of the immune synapse of B-cells. A decrease in Vamp-7 expression does not alter lysosome transport to the synaptic interface but impairs their local secretion, a defect that compromises the ability of B-cells to extract, process, and present immobilized Ag. Thus our results reveal that B-cells rely on the SNARE protein Vamp-7 to promote the local exocytosis of lysosomes at the immune synapse, which is required for efficient Ag extraction and presentation.
Asunto(s)
Linfocitos B/metabolismo , Proteínas R-SNARE/metabolismo , Proteínas R-SNARE/fisiología , Animales , Presentación de Antígeno/inmunología , Antígenos/metabolismo , Linfocitos B/fisiología , Línea Celular , Línea Celular Tumoral , Movimiento Celular , Exocitosis , Lisosomas/metabolismo , Ratones , Transporte de Proteínas , Proteínas SNARE/metabolismo , Sinapsis/metabolismoRESUMEN
One of the greatest advances in medicine during the past century is the introduction of organ transplantation. This therapeutic strategy designed to treat organ failure and organ dysfunction allows to prolong the survival of many patients that are faced with no other treatment option. Today, organ transplantation between genetically dissimilar individuals (allogeneic grafting) is a procedure widely used as a therapeutic alternative in cases of organ failure, hematological disease treatment, and some malignancies. Despite the potential of organ transplantation, the administration of immunosuppressive drugs required for allograft acceptance induces severe immunosuppression in transplanted patients, which leads to serious side effects such as infection with opportunistic pathogens and the occurrence of neoplasias, in addition to the known intrinsic toxicity of these drugs. To solve this setback in allotransplantation, researchers have focused on manipulating the immune response in order to create a state of tolerance rather than unspecific immunosuppression. Here, we describe the different treatments and some of the novel immunotherapeutic strategies undertaken to induce transplantation tolerance.
Asunto(s)
Rechazo de Injerto/prevención & control , Factores Inmunológicos/uso terapéutico , Trasplante de Órganos , Tolerancia al Trasplante/efectos de los fármacos , Citocinas/biosíntesis , Citocinas/inmunología , Células Dendríticas/inmunología , Células Dendríticas/patología , Rechazo de Injerto/inmunología , Rechazo de Injerto/patología , Supervivencia de Injerto/efectos de los fármacos , Supervivencia de Injerto/inmunología , Humanos , Terapia de Inmunosupresión , Inmunosupresores/efectos adversos , Macrófagos/inmunología , Macrófagos/patología , Linfocitos T/inmunología , Linfocitos T/patología , Trasplante HomólogoRESUMEN
T helper type 17 (Th17) lymphocytes are found in high frequency in tumour-burdened animals and cancer patients. These lymphocytes, characterized by the production of interleukin-17 and other pro-inflammatory cytokines, have a well-defined role in the development of inflammatory and autoimmune pathologies; however, their function in tumour immunity is less clear. We explored possible opposing anti-tumour and tumour-promoting functions of Th17 cells by evaluating tumour growth and the ability to promote tumour infiltration of myeloid-derived suppressor cells (MDSC), regulatory T cells and CD4(+) interferon-γ(+) cells in a retinoic acid-like orphan receptor γt (RORγt) -deficient mouse model. A reduced percentage of Th17 cells in the tumour microenvironment in RORγt-deficient mice led to enhanced tumour growth, that could be reverted by adoptive transfer of Th17 cells. Differences in tumour growth were not associated with changes in the accumulation or suppressive function of MDSC and regulatory T cells but were related to a decrease in the proportion of CD4(+) T cells in the tumour. Our results suggest that Th17 cells do not affect the recruitment of immunosuppressive populations but favour the recruitment of effector Th1 cells to the tumour, thereby promoting anti-tumour responses.
Asunto(s)
Tolerancia Inmunológica , Neoplasias/inmunología , Células TH1/inmunología , Células Th17/inmunología , Animales , Línea Celular Tumoral , Ratones , Ratones Mutantes , Neoplasias/genética , Neoplasias/patología , Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares/genética , Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares/inmunología , Células TH1/patología , Células Th17/patologíaRESUMEN
Objetivo: cuantificar la aceleración del proceso de cicatrización deheridas crónicas, que genera la utilización de un apósito bioactivocon carga iónica, frente a su no utilización.Método: estudio experimental aleatorizado en dos grupos y multicéntrico,realizado con 122 pacientes (61 lesiones fueron incluidas enel grupo control y otras 61 en el de actuación). Todos los pacientesfueron tratados del mismo modo, con la única diferencia de la aplicacióno no del apósito bioactivo con carga iónica. El seguimiento dela evolución del proceso de cicatrización fue llevado a cabo duranteun mes, con registro de los parámetros del estudio los días cero,quince y treinta. Las variables resultado fueron la superficie y el volumende la herida, así como la cicatrización de la lesión.Resultados: el día cero ambos grupos eran homogéneos, no existiendodiferencias estadísticamente significativas en los parámetrosvolumen o superficie. Al final del seguimiento (30 días), la superficiese redujo un 39% en el grupo control, frente a una reduccióndel 71,2% en el grupo de actuación. La reducción del volumen fuede un 37,1% en el grupo control, frente al 75,3% en el grupo deactuación. Durante esos mismos treinta días, 14 heridas cerraronen el grupo de actuación, 4 heridas incluidas en el grupo controlcerraron en el mismo periodo.Conclusión: el apósito bioactivo con carga iónica, heridas conabundante tejido de granulación, acorta el tiempo de cicatrización,ya que duplica la velocidad de cierre de las mismas
Objective: To quantify the acceleration of the healing process inchronic wounds promoted by the use of an ionically charged bioactivedressing as opposed to its non utilisation.Method: Randomised experimental study in two groups, and multicentricstudy, carried out on 122 patients (61 lesions were included inthe control group and a further 61 in the intervention group). Allpatients were treated identically, with the only difference in the applicationor non-application of the ionically charged bioactive dressing.Follow up of the healing process was carried out over a month, withregistry of the study parameters on days 0, 15 and 30. The outcomevariables were the surface and the volume of the wound as well asthe healing of the lesion.Results: At baseline, both groups were homogenous, with no statisticallysignificant differences in the parameters of volume and surfaceextension. At completion of the follow up (30 days), the surface hadreduced by 39% in the control group vs. a 71,2 % reduction in theintervention group, volume had reduced by 37,1% in the controlgroup vs. a 75,3% in the intervention group. During the same 30-day period, 14 wounds in the intervention group and only 4 woundsin the control group closed during the implementation period.Conclusion: Ionically charged dressing doubles speed wound healingprocess when it is applied on clean wounds, so it shortens the healingtime